Aethlon Medical, Inc. (AEMD) Publications https://www.aethlonmedical.com/news-media/publications/rss en-us https://d1io3yog0oux5.cloudfront.net/aethlonmedical/files/aethlon-logo.png Aethlon Medical, Inc. Logo https://www.aethlonmedical.com Equisolve Investor Relations Suite <![CDATA[Hemopurifier device in patients with solid tumours who have stable or progressive disease while on a treatment that includes pembrolizumab or nivolumab: protocol for an Australian safety, feasibility and dose-finding study]]> https://bmjopen.bmj.com/content/16/1/e102581.full Mon, 05 Jan 26 00:00:00 -0500 https://bmjopen.bmj.com/content/16/1/e102581.full <![CDATA[Increased mannosylation of extracellular vesicles in Long COVID plasma provides a potential therapeutic target for Galanthus nivalis agglutinin (GNA) affinity resin]]> https://www.biorxiv.org/content/10.1101/2025.11.21.689519v1 Thu, 20 Nov 25 00:00:00 -0500 https://www.biorxiv.org/content/10.1101/2025.11.21.689519v1 <![CDATA[Ex Vivo Removal of CD41 positive platelet microparticles from Plasma by a Medical Device containing a Galanthus nivalis agglutinin (GNA) affinity resin]]> https://www.biorxiv.org/content/10.1101/2025.05.09.652772v1 Sun, 11 May 25 00:00:00 -0400 https://www.biorxiv.org/content/10.1101/2025.05.09.652772v1 <![CDATA[A lectin affinity plasmapheresis device removes extracellular vesicles and microRNAs from renal perfusates following controlled oxygenated rewarming of discarded donor kidneys]]> https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4942/pdf/1-s2.0-S0966327425000437-main.pdf Thu, 27 Feb 25 00:00:00 -0500 https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4942/pdf/1-s2.0-S0966327425000437-main.pdf <![CDATA[Removal of Clinically Relevant SARS-CoV-2 Variants by An Affinity Resin Containing Galanthus nivalis Agglutinin]]> https://www.biorxiv.org/content/10.1101/2022.04.27.489436v1 Thu, 28 Apr 22 00:00:00 -0400 https://www.biorxiv.org/content/10.1101/2022.04.27.489436v1 <![CDATA[Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection]]> https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4556/pdf/fmed-08-744141.pdf Fri, 08 Oct 21 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4556/pdf/fmed-08-744141.pdf <![CDATA[Lectin Affinity Plasmapheresis for Middle East Respiratory Syndrome-Coronavirus and Marburg Virus Glycoprotein Elimination]]> https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4557/pdf/Lectin+Affinity+Plasmapheresis+for+Middle+East+Respiratory+Syndrome-Coronavirus+and+Marburg+Virus+Glycoprotein+Elimination+-+PMC.pdf Thu, 26 Apr 18 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4557/pdf/Lectin+Affinity+Plasmapheresis+for+Middle+East+Respiratory+Syndrome-Coronavirus+and+Marburg+Virus+Glycoprotein+Elimination+-+PMC.pdf <![CDATA[ Extracorporeal Virus Elimination for the Treatment of Severe Ebola Virus Disease – First Experience with Lectin Affinity Plasmapheresis]]> https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4555/pdf/Extracorp+virus+elmination_Ebola+Virus+Disease.pdf Wed, 11 Feb 15 00:00:00 -0500 https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4555/pdf/Extracorp+virus+elmination_Ebola+Virus+Disease.pdf <![CDATA[Exosome removal as a therapeutic adjuvant in cancer]]> https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4554/pdf/Exosme+removal+as+therapeutic+adjuvant+in+cancer.pdf Wed, 27 Jun 12 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4554/pdf/Exosme+removal+as+therapeutic+adjuvant+in+cancer.pdf <![CDATA[Modeling Hepatitis C Virus Therapies Combining Drugs and Lectin Affinity Plasmapheresis ]]> https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4552/pdf/Modeling+HepC+Theraies+combo+drug+and+lectin+affinity+plasmapheresis.pdf Fri, 08 Jan 10 00:00:00 -0500 https://d1io3yog0oux5.cloudfront.net/_f77b6c097abee62d6b00bba432cad3a3/aethlonmedical/db/575/4552/pdf/Modeling+HepC+Theraies+combo+drug+and+lectin+affinity+plasmapheresis.pdf